Navigation Links
The Outlook for Pharmaceuticals in Western Europe
Date:12/13/2012

stern European markets, with increasing investment in expensive, innovative products to treat chronic diseases, such as cancer. The investment from hospitals into new drugs will offset the falling prices of mature drugs that are soon to go off patent. There are opportunities to further explore biotechnology advances and reformulations, which will drive the market forward in the long term.

THESE REPORTS ANALYSE THE ISSUES The Outlook for Pharmaceutical Markets in Western Europe is a unique collection of management reports from Espicom Business Intelligence. Each report provides individual and highly-detailed analysis of each market, looking at key regulatory, political, economic and corporate developments in the wider context of market structure, service and access. The reports are available individually, or as a discounted collection, and prices include four completely updated reports sent quarterly, together with a comprehensive statistical appendix. There are over 60 markets covered in the worldwide series. HIGHLIGHTS FROM THE REGION FRANCE

France has one of the highest pharmaceutical per capita consumption levels in the world. The French pharmaceutical market is also one of the world's largest. Overall pharmaceutical market growth has been comparatively low in recent years and is expected to average a moderate CAGR in the medium term, with government cost-containment programmes exerting downward pressure on reimbursable products. The hospital market has been much more dynamic with growth rates twice this figure in recent years, although growth rates are now falling due to greater regulatory controls in this sector and fewer innovative drugs coming to market. The underdeveloped generics market is undergoing rapid expansion, boosted by government incentives and the loss of patent protection for several high-volume products. The stagnating OTC market has also started to expand, as a result of government moves to end reimbursement for a wide range of products
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. The Outlook for Pharmaceuticals in South East Asia
2. The Outlook for Pharmaceuticals in Latin America
3. E7: The Outlook for Pharmaceuticals to 2012
4. The Outlook for Pharmaceuticals in Central & Eastern Europe
5. CVS Caremark Provides Strong Growth Outlook for 2013 and Beyond, Announces 38%Dividend Increase and Outlines Strategic Growth Framework
6. World Diagnostic Imaging Market Outlook and Leading Suppliers Business Strategies and Marketing Tactics
7. Cytos Biotechnology Ltd Reports Third Quarter 2012 Financial Results, Recent Development and Outlook
8. South and Central America Patient Monitoring Market Outlook to 2018 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors and Others
9. PDI, Inc. Announces New Multi-Year Win Valued At up to $150 Million and Provides Outlook for 2012
10. Japan Pharma Review: Outlook to 2017
11. South and Central America Orthopedic Devices Market Outlook to 2018 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... 2014  ResMed (NYSE: RMD ) ... Exchange program, a comprehensive suite of software and ... other health care providers. ResMed ... patient information. It integrates valuable sleep and respiratory ... management platforms with customers, in-house or third-party electronic ...
(Date:10/20/2014)... , Oct. 20, 2014   Taiho Oncology, ... Ltd. ( Japan ), announced that ... Fast Track designation for TAS-102 (nonproprietary names: trifluridine ... under investigation for the treatment of refractory metastatic ... initiated a rolling NDA submission to the FDA. ...
(Date:10/20/2014)... LONDON , October 20, 2014 ... study of its novel, low volume bowel preparation, NER1006, ... of the American College of Gastroenterology (ACG), ... end point of stool weight and co-primary endpoint of ... efficacy with NER1006 vs. MOVIPREP ® in screening ...
Breaking Medicine Technology:ResMed Launches ResMed Data Exchange 2Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 2Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 3Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 4Positive Results from Phase II Data Show NER1006 Achieves High Quality Bowel Cleansing Efficacy 2
... 7 MO BIO Laboratories, Inc., the ... announces the launch of a groundbreaking new product, LifeGuard ... samples upon collection. LifeGuard solution will enable researchers ... degradation or changes in transcript levels during transport to ...
... RIDGE, N.J., Oct. 7 With the growth in the ... WIRELESS I.T. & Entertainment 2009® that it is offering OnCare ... Manager application that helps address the specific needs of mobile ... efficient. , Designed specifically for use by home ...
Cached Medicine Technology:MO BIO Laboratories, Inc. Launches LifeGuard(TM) Soil Preservation Solution 2Verizon Wireless Offers Home Health Care Industry Custom Mobile Application To Be More Productive 2
(Date:10/20/2014)... October 20, 2014 Zereana Jess-Huff, a 34-year-old ... Maryland 2014 on a platform to think outside the bra. ... uses her position to raise awareness about women’s other lady ... breast cancer. You say the color pink and everybody knows ... for a fact that it has not been won when ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 ... Voicheck as Assistant Director of their CentralSource ... in managing the innovative turnkey drug sourcing, distribution, ... Matthew brings over 12 years of industry experience, ... Myoderm at the peak of their international success ...
(Date:10/20/2014)... Final Cut Pro X Plugin developers from ... theme for FCPX filmmakers . , “Fun, cool, and ... Citrus theme” Says Christina Austin, CEO of Pixel Film Studios. ... , Citrus comes with all the tools needed for a ... transitions for added style, a title screen for an introduction, ...
(Date:10/20/2014)... October 20, 2014 Do you ever ... Here comes a wonderful app Metassessor for teachers, specialists ... company helped its client “Intervention Development LLC” to ... app is designed for iOS 4.3 or later and ... app is optimized for iPhone 5. It is now ...
(Date:10/19/2014)... Dallas, Texas (PRWEB) October 20, 2014 ... therapeutic development for Partial Seizure, complete with comparative ... target, mechanism of action (MoA), route of administration ... and featured news and press releases. It also ... for Partial Seizure and special features on late-stage ...
Breaking Medicine News(10 mins):Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:Myoderm Hires Matthew Voicheck to Lead Turnkey Drug Sourcing Service 2Health News:Today Pixel Film Studios Announced the Release of the Citrus theme for Final Cut Pro X 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 4
... Ramadoss has added a new twist to the cola row ... added pesticides.// , ,"All carbonated drinks like Pepsi and ... a comprehensive policy on such drinks are needed," he said ... of Madras Medical College. ,Ramadoss added that the issue ...
... and Prevention say that mothers who are at a low-risk ... deliver their baby by C-section// rather than vaginally. The report ... Perinatal Care. For the study researchers looked at 5.7 million ... ,In general, neonatal ( ,The overall rate ...
... Boston have discovered a new common, noncoding variant in ... with age-related macular degeneration// (AMD), the leading cause ... 60 and older. Their analyses, for the first time, ... to estimate individual risk of advanced AMD. They observed ...
... people and the possible link between these changes and the ... Forest University School of Medicine// . ,Comparison of ... disorder with the tissue from normal people will be done ... from the National Institute of Mental Health. ,The ...
... Institutet in Sweden and Makerere University in Uganda finds that ... and this is the reason for pregnant women and children ... worst of the four malaria parasites that infect man. It ... of pregnant women, with fatal consequences for both her and ...
... claim to have discovered how a specific chemotherapy drug helps ... was conducted on the use of a virus in animals ... led by scientists from the Ohio State University Comprehensive Cancer ... Research Institute, and has been published in the August 22nd ...
Cached Medicine News:Health News:Cesarean Section May Increase Infant Mortality Rates in Low-Risk Women 2Health News:AMD influenced by Variation in 3 Genes 2Health News:AMD influenced by Variation in 3 Genes 3Health News:Brain changes in schizophrenia to be analyzed 2Health News:Brain changes in schizophrenia to be analyzed 3Health News:Malarial Parasite Hides In Placenta 2Health News:Cancer Drug Helps An Anti-Cancer Virus To Act More Exhaustively 2Health News:Cancer Drug Helps An Anti-Cancer Virus To Act More Exhaustively 3
Designated most popular model or size. Double-ended. 2 mm wide....
Heavy. 7.5 mm curved tip....
Desmarres Infant Retractor...
2.0 mm cup , straight shaft, Flat handle, length 125.0 mm....
Medicine Products: